JP6513643B2 - トリヒドロキシフェニル基を含む化合物を使用する基体上の活性剤の固定化 - Google Patents

トリヒドロキシフェニル基を含む化合物を使用する基体上の活性剤の固定化 Download PDF

Info

Publication number
JP6513643B2
JP6513643B2 JP2016518024A JP2016518024A JP6513643B2 JP 6513643 B2 JP6513643 B2 JP 6513643B2 JP 2016518024 A JP2016518024 A JP 2016518024A JP 2016518024 A JP2016518024 A JP 2016518024A JP 6513643 B2 JP6513643 B2 JP 6513643B2
Authority
JP
Japan
Prior art keywords
substrate
trihydroxyphenyl
group
solution
active agent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016518024A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016520403A (ja
JP2016520403A5 (https=
Inventor
トン ザット ハイ，
トン ザット ハイ，
ジョン−ブルース デボルト グリーン，
ジョン−ブルース デボルト グリーン，
ティモシー マイケル フルガム，
ティモシー マイケル フルガム，
フィリップ バイロン メッサースミス，
フィリップ バイロン メッサースミス，
タダス スタニスロバス シレイカ，
タダス スタニスロバス シレイカ，
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Baxter Healthcare SA
Baxter International Inc
Original Assignee
Baxter Healthcare SA
Baxter International Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Baxter Healthcare SA, Baxter International Inc filed Critical Baxter Healthcare SA
Publication of JP2016520403A publication Critical patent/JP2016520403A/ja
Publication of JP2016520403A5 publication Critical patent/JP2016520403A5/ja
Application granted granted Critical
Publication of JP6513643B2 publication Critical patent/JP6513643B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08K—Use of inorganic or non-macromolecular organic substances as compounding ingredients
    • C08K5/00—Use of organic ingredients
    • C08K5/04—Oxygen-containing compounds
    • C08K5/13—Phenols; Phenolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/08—Ethers or acetals acyclic, e.g. paraformaldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/28—Materials for coating prostheses
    • A61L27/34—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/08—Materials for coatings
    • A61L29/085—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L29/00—Materials for catheters, medical tubing, cannulae, or endoscopes or for coating catheters
    • A61L29/14—Materials characterised by their function or physical properties, e.g. lubricating compositions
    • A61L29/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/042—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A61L31/10—Macromolecular materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54353—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals with ligand attached to the carrier via a chemical coupling agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/551—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being inorganic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials For Medical Uses (AREA)
JP2016518024A 2013-06-07 2014-06-06 トリヒドロキシフェニル基を含む化合物を使用する基体上の活性剤の固定化 Active JP6513643B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361832488P 2013-06-07 2013-06-07
US201361832477P 2013-06-07 2013-06-07
US61/832,488 2013-06-07
US61/832,477 2013-06-07
PCT/US2014/041240 WO2014197768A1 (en) 2013-06-07 2014-06-06 Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups

Publications (3)

Publication Number Publication Date
JP2016520403A JP2016520403A (ja) 2016-07-14
JP2016520403A5 JP2016520403A5 (https=) 2017-06-22
JP6513643B2 true JP6513643B2 (ja) 2019-05-15

Family

ID=51176459

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016518024A Active JP6513643B2 (ja) 2013-06-07 2014-06-06 トリヒドロキシフェニル基を含む化合物を使用する基体上の活性剤の固定化

Country Status (9)

Country Link
US (2) US9655917B2 (https=)
EP (1) EP3003413B1 (https=)
JP (1) JP6513643B2 (https=)
KR (1) KR102271653B1 (https=)
CN (1) CN105377315B (https=)
AU (1) AU2014274766B2 (https=)
CA (1) CA2914732C (https=)
ES (1) ES2660595T3 (https=)
WO (1) WO2014197768A1 (https=)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2012036238A1 (ja) * 2010-09-17 2014-02-03 テルモ株式会社 血液と接触する表面の血小板付着性を減少させる医療用機器の製造方法
CA2906621A1 (en) 2013-03-15 2014-09-25 Baxter International Inc. Immobilization of active agent on a substrate
KR102271653B1 (ko) 2013-06-07 2021-07-05 백스터 인터내셔널 인코포레이티드 트리하이드록시페닐기를 포함하는 화합물을 사용한 기판 상에의 활성제의 고정화
WO2017147145A1 (en) * 2016-02-23 2017-08-31 The Regents Of The University Of California Macrocyclic polyphenols for universal coatings
WO2017188214A1 (ja) * 2016-04-25 2017-11-02 学校法人早稲田大学 高い接着性を有する非水溶性自立性薄膜
CN106119820B (zh) * 2016-06-01 2018-06-22 华南理工大学 一种利用可控接枝技术提高材料表面血液相容性的方法
CN107435043A (zh) * 2017-07-30 2017-12-05 光合强化（北京）生物科技有限公司 基于聚碳酸酯改性的用于固定甲拌磷降解菌的功能材料
CN108310473A (zh) * 2018-01-31 2018-07-24 采纳科技股份有限公司 注射针硅油涂层材料及涂覆此涂层的注射针
MX2021006372A (es) * 2018-11-29 2021-08-11 Ethicon Inc Revestimientos lubricantes de silicona curada a baja temperatura.
WO2020263704A1 (en) * 2019-06-25 2020-12-30 Molecular Surface Technologies, Llc Electrochemical attachment of phosphonic acids to metallic substrates and antimicrobial medical devices containing same
CN110665374B (zh) * 2019-09-19 2022-01-28 深圳安吉尔饮水产业集团有限公司 季铵盐抗菌材料的制备方法及其制备的抗菌材料
CN110694488B (zh) * 2019-09-19 2022-01-28 深圳安吉尔饮水产业集团有限公司 一种抗菌过滤材料及其应用
US11718753B2 (en) 2020-05-28 2023-08-08 Ethicon, Inc. Topical skin closure compositions and systems
US12528913B2 (en) 2020-05-28 2026-01-20 Ethicon, Inc. Antimicrobial anhydrous topical skin closure compositions and systems
US11518604B2 (en) 2020-05-28 2022-12-06 Ethicon, Inc. Systems, methods and devices for aerosol spraying of silicone based topical skin adhesives for sealing wounds
US11479669B2 (en) 2020-05-28 2022-10-25 Ethicon, Inc. Topical skin closure compositions and systems
US11712229B2 (en) 2020-05-28 2023-08-01 Ethicon, Inc. Systems, devices and methods for dispensing and curing silicone based topical skin adhesives
US12465577B2 (en) 2020-05-28 2025-11-11 Ethicon, Inc. Antimicrobial topical skin closure compositions and systems
US11589867B2 (en) 2020-05-28 2023-02-28 Ethicon, Inc. Anisotropic wound closure systems
CN112843342A (zh) * 2021-01-18 2021-05-28 成都鼎峰前瞻科技有限公司 具有生物抗污功能的材料、其制备方法及应用
CN115245813B (zh) * 2021-04-25 2023-09-26 中国科学院大连化学物理研究所 一种复合微球及其制备和在磷酸化肽吸附中的应用

Family Cites Families (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1491218C3 (de) 1963-06-15 1973-01-04 Spofa Sdruzheni Podniku Pro Zdravotnickou Vyrobu, Prag Blutgefäßprothese und Verfahren zur Herstellung derselben
JPS51101077A (https=) 1975-03-04 1976-09-07 Konishiroku Photo Ind
DK402785D0 (da) 1985-09-03 1985-09-03 Syn Tek Ab Fremgangsmaade til fremstilling af et enzym
US5242432A (en) 1991-09-26 1993-09-07 Ivac Needleless adapter
US5360413A (en) 1991-12-06 1994-11-01 Filtertek, Inc. Needleless access device
DE69233329T2 (de) 1991-12-18 2004-08-05 Icu Medical, Inc., Irvine Verfahren zum Flüssigkeitstransfer
US5782816A (en) 1995-09-07 1998-07-21 David R. Kipp Bi-directional valve and method of using same
US5730418A (en) 1996-09-30 1998-03-24 The Kipp Group Minimum fluid displacement medical connector
DK0952868T3 (da) 1996-11-18 2004-07-19 Nypro Inc Aftörbar ventil med Luer-konus
JP4023561B2 (ja) 1997-05-20 2007-12-19 バクスター インターナショナル インコーポレイテッド ニードルレスコネクター
EP1043720A1 (en) 1999-04-07 2000-10-11 Agfa-Gevaert N.V. Heat mode recording element based on a thin metal layer
US7618937B2 (en) 2001-07-20 2009-11-17 Northwestern University Peptidomimetic polymers for antifouling surfaces
US7858679B2 (en) 2001-07-20 2010-12-28 Northwestern University Polymeric compositions and related methods of use
US7682669B1 (en) * 2001-07-30 2010-03-23 Advanced Cardiovascular Systems, Inc. Methods for covalently immobilizing anti-thrombogenic material into a coating on a medical device
US6651956B2 (en) 2002-01-31 2003-11-25 Halkey-Roberts Corporation Slit-type swabable valve
US20030208165A1 (en) 2002-05-01 2003-11-06 Christensen Kelly David Needless luer access connector
DE10393059D2 (de) 2002-05-09 2005-05-04 Hemoteq Gmbh Verbindungen und Verfahren zur hemokompatiblen Beschichtung von Oberflächen
DE60333566D1 (de) * 2002-08-13 2010-09-09 Medtronic Inc Medizinische vorrichtung mit verbesserter haftung zwischen einem polymeren berzug und einem substrat
JP2004217540A (ja) 2003-01-10 2004-08-05 Mitsubishi Chemicals Corp 没食子酸配糖体の製造方法
EP1735456A4 (en) 2004-02-27 2011-11-16 Univ Northwestern POLYMERIC COMPOSITION AND ASSOCIATED METHOD OF USE
JP5028605B2 (ja) * 2004-11-22 2012-09-19 国立大学法人九州大学 バイオフィルム形成阻害剤及び治療用器具
US20070282422A1 (en) * 2006-05-10 2007-12-06 Cook Incorporated Medical devices and methods for local delivery of elastin-stabilizing compounds
US20080107564A1 (en) 2006-07-20 2008-05-08 Shmuel Sternberg Medical fluid access site with antiseptic indicator
US20080021392A1 (en) 2006-07-20 2008-01-24 Lurvey Kent L Medical fluid access site with antiseptic indicator
WO2008091386A2 (en) 2006-08-04 2008-07-31 Northwestern University Biomimetic modular adhesive complex: material, methods and applications therefore
AU2007283772B2 (en) 2006-08-04 2013-03-07 Kensey Nash Corporation Biomimetic compounds and synthetic methods therefor
WO2008080162A2 (en) * 2006-12-22 2008-07-03 The Johns Hopkins University Anti-cholesterolemic compounds and methods of use
US8673286B2 (en) 2007-04-09 2014-03-18 Northwestern University DOPA-functionalized, branched, poly(aklylene oxide) adhesives
US8383092B2 (en) 2007-02-16 2013-02-26 Knc Ner Acquisition Sub, Inc. Bioadhesive constructs
US9028691B2 (en) 2007-02-27 2015-05-12 Deka Products Limited Partnership Blood circuit assembly for a hemodialysis system
ES2387699T3 (es) 2007-02-28 2012-09-28 Dsm Ip Assets B.V. Recubrimiento hidrófilo
JP2008253707A (ja) * 2007-04-05 2008-10-23 Bio Verde:Kk 薬剤溶出ステント
US20090024096A1 (en) 2007-07-20 2009-01-22 Baxter International Inc. Immobilization of dyes and antimicrobial agents on a medical device
US9125973B2 (en) 2007-07-20 2015-09-08 Baxter International Inc. Antimicrobial housing and cover for a medical device
WO2009062146A2 (en) 2007-11-09 2009-05-14 Northwestern University Substrate-independent layer-by-layer assembly using catechol-functionalized polymers
WO2010014940A2 (en) 2008-07-31 2010-02-04 Northwestern University Surface-immobilized antimicrobial peptoids
US20100137903A1 (en) 2008-09-26 2010-06-03 Nerites Corporation Bioadhesive constructs
WO2010037045A1 (en) 2008-09-28 2010-04-01 Nerites Corporation Multi-armed catechol compound blends
WO2010037395A2 (en) 2008-10-01 2010-04-08 Dako Denmark A/S Mhc multimers in cancer vaccines and immune monitoring
US20100297745A1 (en) 2009-05-19 2010-11-25 Nanyang Technological University Flow-through method of functionalizing inner surfaces of a microfluidic device
US8591932B2 (en) 2009-09-17 2013-11-26 W. L. Gore & Associates, Inc. Heparin entities and methods of use
KR101257996B1 (ko) * 2010-11-01 2013-04-30 아주대학교산학협력단 폴리페놀산화효소를 이용한 생리활성 물질의 표면 고정화 방법
US9320826B2 (en) 2010-11-09 2016-04-26 Kensey Nash Corporation Adhesive compounds and methods use for hernia repair
US9273238B2 (en) 2011-02-23 2016-03-01 Yaolin ZHANG Process for fungal modification of lignin and preparing wood adhesives with the modified lignin and wood composites made from such adhesives
US9937255B2 (en) * 2011-05-18 2018-04-10 Nectero Medical, Inc. Coated balloons for blood vessel stabilization
WO2013033168A1 (en) 2011-08-30 2013-03-07 Mast Biosurgery Ag Polyactic acid/alginate containing surgical barrier
SG11201401329VA (en) * 2011-10-14 2014-05-29 Innora Gmbh Improved formulations for drug-coated medical devices
WO2013172966A1 (en) * 2012-05-14 2013-11-21 Children's Medical Center Corporation Systems and methods for extracorporeal blood modification
US10179114B2 (en) * 2013-01-24 2019-01-15 Northwestern University Phenolic coatings and methods of making and using same
CA2906621A1 (en) * 2013-03-15 2014-09-25 Baxter International Inc. Immobilization of active agent on a substrate
KR102271653B1 (ko) 2013-06-07 2021-07-05 백스터 인터내셔널 인코포레이티드 트리하이드록시페닐기를 포함하는 화합물을 사용한 기판 상에의 활성제의 고정화

Also Published As

Publication number Publication date
EP3003413A1 (en) 2016-04-13
CN105377315A (zh) 2016-03-02
KR102271653B1 (ko) 2021-07-05
JP2016520403A (ja) 2016-07-14
WO2014197768A1 (en) 2014-12-11
NZ714379A (en) 2021-06-25
CA2914732A1 (en) 2014-12-11
CN105377315B (zh) 2018-11-09
KR20160018650A (ko) 2016-02-17
AU2014274766A1 (en) 2015-12-10
CA2914732C (en) 2019-06-25
HK1216237A1 (zh) 2016-10-28
US20170218174A1 (en) 2017-08-03
US10428200B2 (en) 2019-10-01
ES2660595T3 (es) 2018-03-23
US20140364391A1 (en) 2014-12-11
AU2014274766B2 (en) 2017-12-07
EP3003413B1 (en) 2017-12-13
US9655917B2 (en) 2017-05-23

Similar Documents

Publication Publication Date Title
JP6513643B2 (ja) トリヒドロキシフェニル基を含む化合物を使用する基体上の活性剤の固定化
US9895468B2 (en) Immobilization of an active agent on a substrate
CA2503490C (en) Medical device surface coating comprising bioactive compound
AU2009290833B2 (en) Immobilised biological entities
US8048437B2 (en) Medical device with surface coating comprising bioactive compound
HK1213823B (en) Immobilization of active agent on a substrate
NZ714379B2 (en) Immobilization of an active agent on a substrate using compounds including trihydroxyphenyl groups
HK1216237B (zh) 使用包括三羟基苯基的化合物将活性剂固定在基材上
JP5146945B2 (ja) 抗血栓性コーティング剤及び医療用具

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20151208

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20170512

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20170512

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20180330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180702

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20181203

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190227

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190319

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190410

R150 Certificate of patent or registration of utility model

Ref document number: 6513643

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250